Nitrobenzene carcinogenicity in animals and human hazard evaluation

Toxicology and Industrial Health

Volumn 15, Issue 5, 1999, Pages 445-457

  Holder, James W ^a  

^a U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

Aniline; Carcinogenicity; Free radicals; Nitrosobenzene; Nitroxides; Phenylhydroxylamine

Indexed keywords

ANILINE; CARCINOGEN; CYTOCHROME P450; FREE RADICAL; GLUTATHIONE; HYDROXYLAMINE; NITROBENZENE; NITROSOBENZENE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOASSAY; BREAST TUMOR; CANCER RISK; CARCINOGENICITY; CONTROLLED STUDY; ERYTHROCYTE; FEMALE; GENOTOXICITY; KIDNEY TUMOR; LIVER TUMOR; LUNG TUMOR; MALE; MOUSE; NONHUMAN; OXIDATION REDUCTION REACTION; POLYP; RAT; THYROID TUMOR;

ADMINISTRATION, INHALATION; ANIMALS; CARCINOGENICITY TESTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MALE; MICE; MUTAGENICITY TESTS; NEOPLASMS, EXPERIMENTAL; NITROBENZENES; RATS; RATS, INBRED F344; RISK ASSESSMENT; SAFETY MANAGEMENT; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0033403514     PISSN: 07482337     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (117)

1. Abbinante R., and Pasqualatto D. Intoxication due to ingestion of bitter almond oil contaminated with nitrobenzene. Centro de Información y Asesoramiento Toxicológoco 'Dr. Julio Velasco' (CIATO). Facultad de Farmacia, Universidad Central de Venezuela, Unidad de Cuidados Intensivos, Hospital Miltar 'Carlos Arvelo,' Caracas, Venezuela, pp. 1-12. Abstract of report appears in The Toxicologist 1997: 36 (1): Part 2, Poster 218.
2. Albrecht W., and Neumann H. Biomonitoring of aniline and nitrobenzene: hemoglobin binding in rats and analysis of adducts. Arch. Toxicol. 1985: 57: 1-5.
3. Anonymous. Carcinogenic and Mutagenic Responses to Aromatic Amines and Nitroamines. Elsevier Publishing Co., New York, 1988.
4. Ascherl M., Eyer P., and Kampffmeyer H. Formation and disposition of nitrosochloramphenicol in rat liver. Biochem. Pharmacol. 1985: 34: 3755-3763.
5. Baylin S.B. Tying it all together: epigenetics, genetics, cell cycle, and cancer. Science 1997: 277: 1948-1949.
6. Beauchamp R.O., Irons R.D., Rickert D.E., Couch D.B., and Hamm T.E. A critical review of the literature on nitrobenzene toxicity. CRC Crit. Rev. Toxicol. 1982: 11: 33-83.
7. Belisario M.A., Pecce R., Garofalo A., and Malorni A. Erythrocyte enzymes catalyze 1-nitropyrene and 3-nitrofluoanthene nitroreduction. Toxicology 1996: 108: 101-108.
8. Blaauboer B.J., and Van Holsteijn C.W.M. Formation and disposition of N-hydroxylated metabolites of aniline and nitrobenzene by isolated rat hepatocytes. Xenobiotica 1983: 13: 295-302.
9. Bryant C., and Deluca M. Purification and characterization of an oxygen-insensitive NAD(P)H nitroreductase from Enterobacter cloacae. J. Biol. Chem. 1991: 266: 4119-4125.
10. Butterworth B.E., Smith-Oliver T., Earle L., and Loury D. Use of primary cultures of human hepatocytes in toxicology studies. Cancer Res. 1989: 49: 1075-1084.
11. Camara E., Leder A.E., and Ishikawa Y. CEH data summary: nitrobenzene. In: Chemical Economics Handbook (CEH). 677.8000A-P. SRI, Menlo Park, CA, 1997.
12. Cattley R., Everitt J.I., Gross E.A., Moss O.R., Hamm T.E., and Popp J.A. Carcinogenicity and toxicity of inhaled nitrobenzene in B6C3F1 mice and F344/N and CD rats. Fundam. Appl. Toxicol. 1994: 22: 328-340.
13. Cerutti P.A. Oxy-radicals and cancer. Lancet 1994: 344: 862-863.
14. Chandler W.L. Physiological action of nitrobenzene vapor on animals. In: Station N.Y.A.E. (Ed.), Cornell University Memoir, Vol. 20. Cornell University, Ithaca, NY, 1919, pp. 405-472.
15. Chiu C.W., Lee L.H. Wang C.Y., and Bryan G.T. Mutagenicity of some commercially available nitro compounds for Salmonella typhimurium. Mutat. Res. 1978: 58: 11-22.
16. Chemical Industry Institute of Toxicology (CIIT). A chronic inhalation toxicity study of nitrobenzene in B6C3F1 mice, Fischer 344 rats and Sprague-Dawley (CD) rats. In: Chronic Inhalation Bioassay for Carcinogenicity in Animals, Vols. I and II. Research Triangle Park, NC, 1993, pp. 1-440, 441-836.
17. Collins K., Jacks T., and Pavletich N.P. The cell cycle and cancer. Proc. Natl. Acad. Sci. U.S.A. 1997: 94: 2776-2778.
18. Columbano A., Endoh T., Denda A., and Noguchi O. Effects of cell proliferation and cell death (apoptosis and necrosis) on the early stages of rat hepatocarcinogenesis. Carcinogenesis 1996: 17: 395-400.
19. Comporti M. Three models of free radical-induced cell injury. Chem.-Biol. Interact. 1989: 72: 1-56.
20. Crebelli R., Conti L., Carere A., Bertoli C., and Del Gicomo N. The effect of fuel composition on the mutagenicity of diesel engine exhaust. Mutat. Res. 1995: 346: 167-172.
21. Dellarco V.L., and Prival M.J. Mutagenicity of nitro compounds in Salmonella typhimurium in the presence of flavin mononucleotide in a preincubation assay. Environ. Mol. Mutagen. 1989: 13: 116-127.
22. Delsal G., Loda M., and Pagano M. Cell cycle and cancer: critical events at the G1 restriction point. Crit. Rev. Oncog. 1996: 7: 127-142.
23. Demarini D.M., Shelton M.L., and Bell D.A. Mutation spectra of chemical fractions of a complex mixture: role of nitroarenes in the mutagenic specificity of municipal waste incinerator emissions. Mutat. Res. 1996: 349: 1-20.
24. Dollinger A. Peroral poisoning with nitrobenzene or aniline in the newborn. Monatsschr. Kinderheilkd. 1949: 97: 91-93.
25. Dorigan J., and Hushorn J. Air pollution assessment of nitrobenzene. Hazard Evaluation for U.S. EPA. National Technical Information Service (NTIS) Accession No. PB-257776, 1976, pp. 1-86.
26. Dreher D., and Junod A.F. Role of oxygen free radicals in cancer development. Eur. J. Cancer 1996: 32A: 30-38.
27. Dunlap K.L. Nitrobenzenes and nitrotoluenes. In: Mark H.F., Othmer D.F., Overberger C.G., Seaborg G.T., and Grayson N. (Eds.), Kirk-Othmer Encyclopedia of Chemical Technology, Vol. 15. John Wiley and Sons, New York, 1981, pp. 916-932.
28. Eyer P. Reactions of nitrosobenzene with reduced glutathione. Chem.-Biol. Interact. 1979: 24: 227-239.
29. Eyer P., and Ascherl M. Reactions of para-substituted nitrosoamines with human hemoglobin. Biol. Chem. Hoppe-Seyler 1987: 368: 285-294.
30. Eyer P., and Lierheimer E. Biotransformation of nitrosobenzene in the red blood cell and the role of glutathione. Xenobiotica 1980: 10: 517-526.
31. Eyer P., Kampffmeyer H., Maister H., and Rösch-Oehme E. Biotransformation of nitrosoamine, phenylhydroxylamine, and aniline in the isolated perfused liver. Xenobiotica 1980: 10: 499-516.
32. Eyer P., Lierheimer E., and Schneller M. Reactions of nitrosochloramphenicol in blood. Biochem. Pharmacol. 1984: 33: 2299-2308.
33. Feig D.I., Reid T.M., and Loeb L.A. Reactive oxygen species in tumorigenesis. Cancer Res. 1994: 54: 1890s-1894s.
34. Flohé L., Beckmann R., Giertz H., and Loschen G. Oxygen-centered free radicals as mediators of inflammation. In: Sies H. (Ed.), Oxidative Stress. Academic Press, New York, 1985, pp. 403-435.
35. Foster J.R. The role of cell proliferation in chemically induced carcinogenesis. J. Comp. Pathol. 1997: 116: 113-144.
36. Fouts J.R., and Brodie B.B. The enzymatic reduction of chloramphenicol, p-nitrobenzoic acid and other nitroaromatic compounds in mammals. J. Pharmacol. Exp. Ther. 1957: 119: 197-207.
37. 14C]nitrobenzene in the erythrocyte and spleen of rats and mice. Chem.-Biol. Interact. 1984: 50: 27-37.
38. Goldsworthy T.L., Conolly R.B., and Fransson-Steen R. Reviews in genetic toxicology: apoptosis and cancer risk assessment. Mutat. Res. 1996: 365: 71-90.
39. Gutteridge J.M.C. Lipid peroxidation and antioxidants as biomarkers for tissue damage. Clin. Chem. 1995: 41: 1819-1828.
40. Guyton K.Z., and Kensler T.W. Oxidative mechanisms in carcinogenesis. Br. Med. Bull. 1993: 49: 523-544.
41. Hamm T.E. Ninety-day inhalation study of nitrobenzene in F344 rats, and B6C3F1 mice. Subchronic Bioassay. Docket #12634. Chemical Industry Institute of Toxicology (CIIT), PO Box 12137, Research Triangle Park, NC 27709, 1984, pp. 1-38.
42. Harada N., and Omura T. Participation of cytochrome P450 in the reduction of nitro compounds by rat liver microsomes. J. Biochem. (Tokyo) 1980: 87: 1539-1544.
43. Hashimoto S., Koji T., Kohara N., Kanematsu T., and Nakane P.K. Frequency of apoptosis relates inversely to invasiveness and metastatic activity in human colorectal cancer. Virchows Archiv: an International Journal of Pathology 1997: 431: 241-248.
44. Haworth S.T., Lawlor K., Mortelmans K., Speck W., and Zeiger E. Salmonella mutagenicity test results for 250 chemicals. Environ. Mutagen. 1983: 5: 3-142.
45. Hecht S.S. Recent studies on mechanisms of bioactivation and detoxification of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), a tobacco-specific lung carcinogen. CRC Crit. Rev. Toxicol. 1996: 26: 163-181.
46. Hecht S.S., Carmella S.G., Foiles P.G., and Murphy S.E. Biomarkers for human uptake and metabolic activation of tobacco-specific nitrosoamines. Cancer Res. 1994: 54: 1912s-1917s.
47. Hein D.W. Acetylator phenotype and arylamine-induced carcinogenesis. Biochem. Biophys. Acta 1988: 948: 37-66.
48. Hein D.W., Doll M.A., Fretland A.J., Gray K., Deitz A.C., et al. Rodent models of human acetylation polymorphism: comparisons of recombinant acetyltransferases. Mutat. Res. 1997: 376: 101-106.
49. Hinson J.A., and Mays J.B. Covalent binding of the phenacetin metabolite p-nitrosophenetole to protein. J. Pharmacol. Exp. Ther. 1986: 238: 106-112.
50. Holder J.W. Weight of evidence (WOE) classification for hazardous air pollutants. Internal report on the current carcinogenicity status of 37 hazardous air pollutants. Office of Health and Environmental Assessment, Office of Research and Development, U.S. EPA, Washington, DC, September 28, 1992. 1992.
51. Holder J.W. Nitrobenzene carcinogenicity (CAS No. 98-95-3). U.S. Environmental Protection Agency, 1998. EPA/600/R-95/100. Website: http://www.epa.gov/ncea/nitro.htm.
52. Holder J.W., Elmore E., and Barrett J.C. Gap junction function and cancer. Cancer Res. 1993: 53: 3475-3485.
53. Howard P.C., Beland F.A., and Cerniglia C.E. Reduction of the carcinogen 1-nitropyrene to 1-aminopyrene by the rat intestinal bacteria. Carcinogenesis 1983: 4: 985-990.
54. Huff J.E. Chemical toxicity and carcinogenesis: Is there a causal connection? A comparative morphological evaluation of 1500 experiments. In: Vaino H., Magee P.N., McGregor D.B., et al. (Eds.), Mechanisms of Carcinogenesis in Risk Identification. International Agency for Research on Cancer, Lyon, France, 1992, pp. 437-475.
55. Ikeda M., and Kita A. Excretion of p-nitrophenol and p-aminophenol in the urine of a patient exposed to nitrobenzene. Br. J. Ind. Med. 1964: 21: 210-213.
56. Kadlubar F.F., and Ziegler D.M. Properties of a NADH-dependent N-hydroxy amine reductase isolated from pig liver microsomes. Arch. Biochem. Biophys. 1974: 162: 83-92.
57. Keher J.P. Free radicals as mediators of tissue injury and disease. CRC Crit. Rev. Toxicol. 1993: 23: 21-48.
58. Kensler T.W., Egner P.A., Taffe B.C., and Trush M.A. Role of free radicals in tumor promotion and progression. Prog. Clin. Biol. Res. 1989: 298: 233-248.
59. Kerr J.F.R., Winterford C.M., and Harmon B.V. Apoptosis - its significance in cancer and cancer therapy. Cancer 1994: 73: 2013-2026.
60. Khan M.F., Boor P.J., Gu Y., Alcock N.W., and Ansari G.A.S. Oxidative stress in the splenotoxicity of aniline. Fundam. Appl. Toxicol. 1997: 35: 22-30.
61. Khan M.F., Green S., Ansari G., and Boor P. Phenylhydroxylamine: role in aniline-associated splenic oxidative stress and induction of subendo-cardial necrosis. Toxicol. Sci. 1998: 42: 64-71.
62. Kiese M. The biochemical production of ferrihemiglobin-forming derivatives from aromatic amines, and mechanisms of ferrihemiglobin formation. Pharmacol. Rev. 1966: 18: 1091-1161.
63. Kiese M. Methemoglobinemia: A Comprehensive Treatise. CRC Press, Cleveland, OH, 1974.
64. Kimmick G.G., Bell R.A., and Bostick R.M. Vitamin E and breast cancer: a review. Nutr. Cancer Int. J. 1997: 27: 109-117.
65. Klehr H., Eyer P., and Schäfer W. On the mechanism of reactions of nitrosoarenes with thiols. Biol. Chem. Hoppe-Seyler 1985: 366: 755-760.
66. Kligerman A.D., Erexson G.L., Wilmer J.L., and Phelps M.C. Analysis of cytogenetic damage in rat lymphocytes following in vivo exposure to nitrobenzene. Toxicol. Lett. 1983: 18: 219-226.
67. Kodama M., Kaneko M., Aida M., Inoue F., Nakayama T., and Akimoto H. Free radical chemistry of cigarette smoke and its implication in human cancer. Anticancer Res. 1997: 17: 433-437.
68. Kuroda Y. Genetic and Chemical Factors Affecting Chemical Mutagenesis in Cultured Mammalian Cells. Plenum Press, New York, 1986.
69. Levin S.J. Shoe-dye poisoning - relation to methemoglobin formation. Report of a case in a 2-year-old child. JAMA 1927: 89: 2178-2180.
70. 14C-nitrobenzene by liver microsomes and cecal microflora from Fischer-344 rats. Pharmacologist 1981: 23: 171.
71. Levin A.A., and Dent J.G. Comparison of the metabolism of nitrobenzene by hepatic microsomes and cecal microflora from Fischer-344 rats and the relative importance of each in vivo. Drug Metab. Dispos. 1982: 10: 450-454.
72. Levin A.A., Bus J.S., and Dent J.G. Interactions of nitrobenzene with hepatic microsomes. Evidence for cytochrome P-450 uncoupling. Toxicologist 1982: 2: 17.
73. Maples K., Eyer P., and Mason R.P. Aniline-, phenylhydroxylamine-, and nitrobenzene-induced hemoglobin thiyl free radical formation in vivo and in vitro. Mol. Pharmacol. 1989: 37: 311-318.
74. Maser E. Stress, hormonal changes, alcohol, food constituents and drugs: factors that advance the incidence of tobacco smoke-related cancer? Trends Pharmacol. Sci. 1997: 18: 270-275.
75. Mason R.P. Free-radical intermediates in the metabolism of toxic chemicals. In: Pryor W.A. (Ed.), Free Radicals in Biology, Vol. V. Academic Press, New York, 1982, pp. 161-222.
76. Mason R.P., and Holtzman J.L. The mechanism of microsomal and mitochondrial nitroreductase. Electron spin resonance evidence for nitroaromatic free radical intermediates. Biochemistry 1975: 14: 1626-1632.
77. 2 inhibition of nitroreductase. Biochem. Biophys. Res. Commun. 1975: 67: 1267-1274.
78. Miller J.A. Carcinogenesis by chemicals: an overview - G.H.A. Clowes memorial lecture. Cancer Res. 1970: 30: 559-576.
79. Mitscherlich E. Uber die zusammensetzung des nitrobenzids und sulfobenzids. Ann. Phys. U. Chem. 1834: 31: 625-631.
80. Netke S.P., Roomi M.W., Tsao C., and Niedzwiecki A. Ascorbic acid protects guinea pigs from acute aflatoxin toxicity. Toxicol. Appl. Pharmacol. 1997: 143: 429-435.
81. Paranich L.I., Paranich A.V., Vasilenko N.M., Bugati E.V., and Oritz L. Effects of nitrobenzene and its chlorine derivatives on some parameters of antioxidants homeostasis in rat tissues. Byulleten' Eksperimental 'Noi Biologii I Meditsiny 1993: 116: 402-405.
82. Parke D.V. Detoxication. LXVIII. The metabolism of C14-nitrobenzene in the rabbit and guinea pig. Biochem. J. 1956: 62: 339-346.
83. Peterson P.J., Mason R.P., Hovsepian J., and Holtzman J.L. Oxygen-sensitive and -insensitive nitroreduction by Escherichia coli and rat hepatic microsomes. J. Biol. Chem. 1979: 254: 4009-4014.
84. Peto R., Pike M.C., Day N.E., and Gray R.G. Guideline for simple, sensitive significance tests for carcinogenic effects in long-term animal experiments. In: IARC Monograph Committee (Ed.), Long-Term and Short-Term Screening Assays for Carcinogens: A Critical Appraisal, suppl 2. International Agency for Research on Cancer (IARC), Lyon, France, 1980, pp. 311-426.
85. Piotrowski J., Dutkiewicz B., and Popinska E. Excretion of p-aminophenol and p-nitrophenol in rat urine after intravenous and dermal treatment with nitrobenzene. Bromatol. Chem. Toksykol. 1975: 8: 271-272.
86. Portier M.C., Fullerton N.F., Kinouchi T., Smith B.A., and Beland F.A. DNA adduct formation and tumorigenesis in livers and bladders of mice chronically fed 2-acetylaminofluorene. Carcinogenesis 1991: 12: 895-900.
87. Primiano T., Sutler T.R., and Kensler T.W. Antioxidant-inducible genes. Adv. Pharmacol. 1997: 38: 293-328.
88. Pryor W.A. Cigarette smoke radicals and the role of free radicals in chemical carcinogenicity. Environ. Health Perspect. 1997: 105: 875-882.
89. Reddy B.G., Pohl L.R., and Krishna G. The requirement of the gut flora in nitrobenzene-induced methemoglobinemia in rats. Biochem. Pharmacol. 1976: 25: 1119-1122.
90. Rickert D.E. Toxicity of Nitroaromatic Compounds. Hemisphere Publishing Corp., Washington, DC, 1984.
91. Robinson D., Smith J.N., and Williams R.T. Studies in the detoxication: 40. The metabolism of nitrobenzene in the rabbit, o-, m-, p-nitrophenols and 4-nitrocatecol as metabolites of nitrobenzene. Biochem. J. 1951: 50: 228-238.
92. Rosenkranz H.S. Chemical basis for cell mutation. In: Cimino J.A., and Nadolney C. (Eds.), Cancer and the Environment: Possible Mechanisms of Thresholds for Carcinogens and Other Toxic Substances. Mary Ann Liebert, Inc., New York, 1983, pp. 161-172.
93. Rosenkranz H.S. Mutagenic nitroarenes, diesel emissions, particulate-induced mutations and cancer: an essay on cancer-causation by a moving target. Mutat. Res. 1996: 367: 65-72.
94. Salmowa J., Piotrowski J., and Neuhorn U. Evaluation of exposure to nitrobenzene. Br. J. Ind. Med. 1963: 10: 41-49.
95. Schulte-Herman R., Bursch W., Grasl-Kraupp B., Marian B., Török L., Kahl-Rainer P., and Ellinger A. Concepts of cell death and application to carcinogenesis. Toxicol. Pathol. 1997: 25: 89-92.
96. Sealy R.C., Swartz H.M., and Olive P.L. Electron spin resonance-spin trapping. Detection of superoxide formation during aerobic microsomal reduction of nitro-compounds. Biochem. Biophys. Res. Commun. 1978: 82: 680-684.
97. Sherr C.J. Cancer cell cycles. Science 1996: 274: 1672-1677.
98. Staretz M.E., Murphy S.E., Patten C.J., and Nunes M.G. Comparative metabolism of the tobacco-related carcinogens benzo[a]pyrene, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol and N′-nitrosonomicotine in human hepatic microsomes. Drug Metab. Dispos. 1997: 25: 154-162.
99. Stevens A.M. Cyanosis in infants from nitrobenzene. JAMA 1928: 90: 116.
100. Stevenson A., and Forbes R.P. Nitrobenzene poisoning. J. Pediatr. 1942: 21: 224-228.
101. Stier A., Clauss R., and Lücke A. Redox cycle of stable mixed nitroxides formed from carcinogenic aromatic amines. Xenobiotica 1980: 10: 661-673.
102. Suzuki J., Takahashi N., Kobayashi Y., Miyamae R., Ohsawa M., and Suzuki S. Dependence on Salmonella typhimurium enzymes of mutagenicities of nitrobenzene and its derivatives in the presence of rat-liver S9 and norharmon. Mutat. Res. 1987: 178: 187-193.
103. Tomaszewski J.E., Jerina D.M., and Daly J.W. Deuterium isotope effects during formation of phenols by hepatic monooxygenases. Evidence for an alternative to the arene pathway. Biochemistry 1975: 14: 2024-2031.
104. Travis C.C., Zeng C.X., and Nicholas J. Biological model of ED01 hepatocarcinogenesis. Toxicol. Appl. Pharmacol. 1996: 140: 19-29.
105. Trush M.A., and Kensler T.W. An overview of the relationship between oxidative stress and chemical carcinogenesis. Free Radical Biol. Med. 1991: 10: 201-209.
106. U.S. EPA. Guidelines for carcinogen risk assessment. Federal Register 1986: 51: 33992-34003.
107. U.S. EPA. Respiratory health effects of passive smoking: lung cancer and other disorders. Risk Assessment for the Office of Air and Radiation, Report No. EPA/600/6-90/00F. Office of Research and Development, U.S. Environmental Protection Agency, Washington, DC, 1992.
108. U.S. EPA. Proposed guidelines for carcinogen risk assessment. Federal Register 1996: 61 (79): 17960-18011.
109. Vance W.A., and Levin D.E. Structural features of nitroaromatics that determine mutagenic activity in Salmonella typhimurium. Environ. Mutagen. 1984: 6: 797-811.
110. Verna L., Whysner J., and Williams G.M. 2-Acetylaminofluorene mechanistic data and risk assessment: DNA reactivity, enhanced cell proliferation and tumor initiation. Pharmacol. Ther. 1996: 71: 83-105.
111. Von Oettinger W.F. The aromatic amino and nitro compounds, their toxicity and potential dangers, a review of the literature. Public Health Bulletin 271, U.S. Public Health Service, U.S. Government Printing Office, Washington, DC, 1941.
112. Weinstein I.B. Relevance of cyclin D1 and other molecular markers to cancer chemoprevention. J. Cell. Biochem. 1996: (suppl 25): 23-28.
113. Weisberger J.H., and Weisberger E.K. Biochemical formation and pharmacological, toxicological, and pathological properties of hydroxylamines and hydroxamic acids. Pharmacol. Rev. 1973: 25: 1-66.
114. Wheeler L.A., Soderberg F.B., and Goldman P. The relationship between nitro group reduction and the intestinal microflora. J. Pharmacol. Exp. Ther. 1975: 194: 135-144.
115. Witschi H., Espiritu I., Peake J.L., Wu K., Maronpot R.R., and Pinkerton K.E. The carcinogenicity of environmental tobacco smoke. Carcinogenesis 1997: 18: 575-586.
116. Zeitoun M.M. Nitrobenzene poisoning in infants due to inunction with false bitter almond oil. J. Trop. Pediatr. 1959: 5: 73-75.
117. Zeligs M. Aniline and nitrobenzene poisoning in infants. Arch. Pediatr. 1929: 46: 502-506.